2439-02-3
2439-02-3
Chemical Structure
Kynurenic acid sodium
- CAS. Nr.: 2439-02-3
- Formula:C10H6NNaO3
- Molecular Weight:211.15
IUPAC Name: sodium 4-hydroxyquinoline-2-carboxylate
InChIKey: RCAZGXKUQDXSSK-UHFFFAOYSA-M
SMILES: O=C(C1=NC2=CC=CC=C2C(O)=C1)O[Na]
Biological Activity: Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8.
| Art. -Nr. | Produktname | Reinheit | Beschreibung | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Kynurenic acid sodium | 99.82% | Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Kynurenic acid sodium (Standard) | ≥98% | Kynurenic acid (sodium) (Standard) is the analytical standard of Kynurenic acid (sodium). This product is intended for research and analytical applications. Kynurenic acid sodium, an endogenous tryptophan metabolite, is a broad-spectrum antagonist targeting NMDA, glutamate, α7 nicotinic acetylcholine receptor. Kynurenic acid sodium is also an agonist of GPR35/CXCR8. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
